§ EQUITY
USD

AKTS

AKTIS ONCOLOGY INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
82 increased/new, 20 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
MPM BIOIMPACT LLC4.8M6.7%n/a
EcoR1 Capital, LLC4.8M3.7%n/a
Blue Owl Capital Holdings LP3.2M15.2%n/a
WELLINGTON MANAGEMENT GROUP LLP2.3M0.0%n/a
BlackRock, Inc.2.1M0.0%n/a
RTW INVESTMENTS, LP1.6M0.3%n/a
◇ AC INTELLIGENCE

Top institutional owners for AKTS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER79.7% · 37 holders
QUALITY / COMPOUNDER9.1% · 5 holders
PASSIVE / INDEX7.5% · 7 holders
DEALER / BANK3.1% · 14 holders
TACTICAL / MACRO0.5% · 2 holders
INCOME / DEFENSIVE0.1% · 3 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for AKTS in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention AKTS yet.